These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34622984)

  • 1. Stem cells from exfoliated deciduous teeth transplantation ameliorates Sjögren's syndrome by secreting soluble PD-L1.
    Yang N; Liu X; Chen X; Yu S; Yang W; Liu Y
    J Leukoc Biol; 2022 May; 111(5):1043-1055. PubMed ID: 34622984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryopreserved dental pulp tissues of exfoliated deciduous teeth is a feasible stem cell resource for regenerative medicine.
    Ma L; Makino Y; Yamaza H; Akiyama K; Hoshino Y; Song G; Kukita T; Nonaka K; Shi S; Yamaza T
    PLoS One; 2012; 7(12):e51777. PubMed ID: 23251621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cell transplantation ameliorates Sjögren's syndrome via suppressing IL-12 production by dendritic cells.
    Shi B; Qi J; Yao G; Feng R; Zhang Z; Wang D; Chen C; Tang X; Lu L; Chen W; Sun L
    Stem Cell Res Ther; 2018 Nov; 9(1):308. PubMed ID: 30409219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplantation of SHED prevents bone loss in the early phase of ovariectomy-induced osteoporosis.
    Liu Y; Wang L; Liu S; Liu D; Chen C; Xu X; Chen X; Shi S
    J Dent Res; 2014 Nov; 93(11):1124-32. PubMed ID: 25252877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Labial gland-derived mesenchymal stem cells and their exosomes ameliorate murine Sjögren's syndrome by modulating the balance of Treg and Th17 cells.
    Li B; Xing Y; Gan Y; He J; Hua H
    Stem Cell Res Ther; 2021 Aug; 12(1):478. PubMed ID: 34446113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cell transplantation alleviates experimental Sjögren's syndrome through IFN-β/IL-27 signaling axis.
    Yao G; Qi J; Liang J; Shi B; Chen W; Li W; Tang X; Wang D; Lu L; Chen W; Shi S; Hou Y; Sun L
    Theranostics; 2019; 9(26):8253-8265. PubMed ID: 31754394
    [No Abstract]   [Full Text] [Related]  

  • 7. Tonsil-derived mesenchymal stem cells (T-MSCs) prevent Th17-mediated autoimmune response via regulation of the programmed death-1/programmed death ligand-1 (PD-1/PD-L1) pathway.
    Kim JY; Park M; Kim YH; Ryu KH; Lee KH; Cho KA; Woo SY
    J Tissue Eng Regen Med; 2018 Feb; 12(2):e1022-e1033. PubMed ID: 28107610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulatory properties of stem cells from human exfoliated deciduous teeth.
    Yamaza T; Kentaro A; Chen C; Liu Y; Shi Y; Gronthos S; Wang S; Shi S
    Stem Cell Res Ther; 2010 Mar; 1(1):5. PubMed ID: 20504286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cells  from exfoliated  deciduous  teeth alleviate hyposalivation caused by Sjögren syndrome.
    Du ZH; Ding C; Zhang Q; Zhang Y; Ge XY; Li SL; Yu GY
    Oral Dis; 2019 Sep; 25(6):1530-1544. PubMed ID: 31046162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secreted factors from dental pulp stem cells improve Sjögren's syndrome via regulatory T cell-mediated immunosuppression.
    Matsumura-Kawashima M; Ogata K; Moriyama M; Murakami Y; Kawado T; Nakamura S
    Stem Cell Res Ther; 2021 Mar; 12(1):182. PubMed ID: 33726818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombospondin-derived peptide attenuates Sjögren's syndrome-associated ocular surface inflammation in mice.
    Contreras Ruiz L; Mir FA; Turpie B; Masli S
    Clin Exp Immunol; 2017 Apr; 188(1):86-95. PubMed ID: 28033649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human placenta-derived mesenchymal stem cells ameliorate diabetic kidney disease by modulating the T helper 17 cell/ regulatory T-cell balance through the programmed death 1 / programmed death-ligand 1 pathway.
    Wang J; Liu H; Yue G; Deng Y; Cai W; Xu J
    Diabetes Obes Metab; 2024 Jan; 26(1):32-45. PubMed ID: 37722965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olfactory ecto-mesenchymal stem cell-derived exosomes ameliorate murine Sjögren's syndrome by modulating the function of myeloid-derived suppressor cells.
    Rui K; Hong Y; Zhu Q; Shi X; Xiao F; Fu H; Yin Q; Xing Y; Wu X; Kong X; Xu H; Tian J; Wang S; Lu L
    Cell Mol Immunol; 2021 Feb; 18(2):440-451. PubMed ID: 33408339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human umbilical cord mesenchymal stem cells confer potent immunosuppressive effects in Sjögren's syndrome by inducing regulatory T cells.
    Liu Y; Li C; Wang S; Guo J; Guo J; Fu J; Ren L; An Y; He J; Li Z
    Mod Rheumatol; 2021 Jan; 31(1):186-196. PubMed ID: 31859545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programmed death 1/programmed cell death-ligand 1 pathway participates in gastric surgery-induced imbalance of T-helper 17/regulatory T cells in mice.
    Dong L; Zheng X; Wang K; Wang G; Zou H
    J Trauma Acute Care Surg; 2018 Sep; 85(3):549-559. PubMed ID: 29554041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SHED-derived exosomes ameliorate hyposalivation caused by Sjögren's syndrome via Akt/GSK-3β/Slug-mediated ZO-1 expression.
    Du Z; Wei P; Jiang N; Wu L; Ding C; Yu G
    Chin Med J (Engl); 2023 Nov; 136(21):2596-2608. PubMed ID: 37052137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulatory effects of umbilical mesenchymal stem cell-derived exosomes on CD4
    Ma D; Wu Z; Zhao X; Zhu X; An Q; Wang Y; Zhao J; Su Y; Yang B; Xu K; Zhang L
    Inflammopharmacology; 2023 Aug; 31(4):1823-1838. PubMed ID: 37012581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous programmed death ligand-1 restrains the development and onset of Sjӧgren's syndrome in non-obese diabetic mice.
    Zhou J; Jin JO; Kawai T; Yu Q
    Sci Rep; 2016 Dec; 6():39105. PubMed ID: 27966604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dental follicle mesenchymal stem cells ameliorated glandular dysfunction in Sjögren's syndrome murine model.
    Genç D; Bulut O; Günaydin B; Göksu M; Düzgün M; Dere Y; Sezgin S; Aladağ A; Bülbül A
    PLoS One; 2022; 17(5):e0266137. PubMed ID: 35511824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Sjögren's Syndrome with Mesenchymal Stem Cells: A Systematic Review.
    Chihaby N; Orliaguet M; Le Pottier L; Pers JO; Boisramé S
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.